Nasdaq neo.

Nasdaq Data Link brings together millions of financial and economic indicators from over 250 sources on one easy-to-use platform. A Single Interface Most datasets on Nasdaq Data Link are available via API, irrespective of who originally published the data or in what format.That number of contracts represents approximately 549,100 underlying shares, working out to a sizeable 58.2% of NEO's average daily trading volume over the …Nov 29, 2023 · Real time NeoGenomics (NEO) stock price quote, stock graph, news & analysis. FT. MYERS, FL / ACCESSWIRE / October 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report ...

Jan 24, 2022 · NasdaqCM:NEO Earnings Per Share Growth January 24th 2022 It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. NeoGenomics Stock (NASDAQ:NEO) Earnings Dates and Earning Calls. NeoGenomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results ...NeoVolta Inc. Common Stock (NEOV) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

NASDAQ: NeoGenomics Inc (NEO) = 18.17 USD. Provided by Alpha Vantage. NeoGenomics Inc stock (NEO) in USD. 1 NEO = 18.17 USD. 1 tháng. 6 tháng. 1 year. 5 năm. Hold over 40 currencies to convert and send money at any time. Open an account. NeoGenomics Inc stock performance at a glance.NEO עשויה לפרוץ מענף הרפואה, מתמחה בבדיקות גנטיקה של סרטן ושירותי מידע. טכנית, אינדיקטורים תומכים בהמשך מגמה (כגון ממוצעים נעים, MACD) אם כי אינדיקטור RSI – מצביע על קניות יתר. מדווחת ב 27 באוקטובר ...

Nasdaq | NEO U.S.: Nasdaq NeoGenomics Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 1:52 p.m. EST Delayed quote $ 19.46 0.18 0.93% …Nov 15, 2023 · November 15, 2023. Technologies. Neogenomics Inc. (NASDAQ:NEO) has a beta value of 1.25 and has seen 1.03 million shares traded in the last trading session. The company, currently valued at $2.23B, closed the last trade at $17.48 per share which meant it gained $1.4 on the day or 8.71% during that session. 25 may 2016 ... The company's targeted tumor-specific multimodality NeoTYPE profiles, which combine molecular, FISH and IHC testing, are gaining acceptance by ...Dec 1, 2023 · Their NEO share price targets range from $17.00 to $25.00. On average, they expect the company's stock price to reach $19.00 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price. View analysts price targets for NEO or view top-rated stocks among Wall Street analysts.

Oct 5, 2023 · The forecasts range from a low of 17.17 to a high of $27.30. The average price target represents an increase of 70.79% from its latest reported closing price of 12.65. leaderboard of companies ...

Home NEO • NASDAQ NeoGenomics, Inc. Follow Share $18.63 Nov 29, 12:15:06 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Veracyte Inc $26.23 VCYT1.73% Natera Inc $56.61 NTRA2.91%...

Dec 1, 2023 · NEO Earnings Date and Information. NeoGenomics last released its quarterly earnings data on November 6th, 2023. The medical research company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.05. The firm had revenue of $151.95 million for the quarter, compared to analyst estimates of ... FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the …Description. A stock index simply represents a basket of underlying stocks. Indexes can be either price-weighted or capitalization-weighted. In a price-weighted index, such as the Dow Jones Industrial Average, the individual stock prices are simply added up and then divided by a divisor, meaning that stocks with higher prices have a higher weighting in the index …NeoGenomics (NEO) shares ended the last trading session 7.9% higher at $48.23. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.NEONASDAQ NEONASDAQ 19.23USD −0.05 −0.29% As of today at 09:11 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast NEO chart Today …

One great example is NeoGenomics, Inc. ( NASDAQ:NEO) which saw its share price drive 125% higher over five years. On top of that, the share price is up 77% in about a quarter. The company reported ...NEO Finance AB Metinė informacija Pateikiama NEO Finance, AB (toliau – Bendrovė) metinė informacija už 2022 m. – audituotas metinių. Daugiau naujienų. Reguliuojama Lietuvos banko. Listinguojama NASDAQ biržoje.Neo has not necessarily become a bad company overnight - in 2021, revenues came in at $484m, which was a 9% year-on-year uplift, and 16% discounting COVID PCR test revenues from 2020, net loss was ...FT. MYERS, FL / ACCESSWIRE / October 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report ...6 jun 2023 ... Latest Neogenomics Inc (NEO:NAQ) share price with interactive charts ... NEO:NAQNASDAQ; Germany; NG9:BERBerlin Stock Exchange · NG9:MUNMunich ...As of October 5, 2023, the average one-year price target for Neogenomics is 21.61. The forecasts range from a low of 17.17 to a high of $27.30. The average price target represents an increase of ...NeoGenomics Price Performance. Shares of NASDAQ:NEO opened at $16.08 on Tuesday. The company has a quick ratio of 6.06, a current ratio of 6.32 and a debt-to-equity ratio of 0.57. NeoGenomics, Inc ...

Dec 1, 2023 · NEO Earnings Date and Information. NeoGenomics last released its quarterly earnings data on November 6th, 2023. The medical research company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.05. The firm had revenue of $151.95 million for the quarter, compared to analyst estimates of ... Swiss National Bank raised its position in shares of NeoGenomics, Inc. ( NASDAQ:NEO – Free Report) by 7.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities ...

Rhumbline Advisers lowered its stake in NeoGenomics, Inc. ( NASDAQ:NEO – Free Report) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange ...Nov 8, 2023 · NeoGenomics Stock Performance. Shares of NASDAQ:NEO opened at $16.73 on Tuesday. The company has a market cap of $2.13 billion, a price-to-earnings ratio of -18.18 and a beta of 1.23. The company ... Oct 5, 2023 · As of October 5, 2023, the average one-year price target for Neogenomics is 21.61. The forecasts range from a low of 17.17 to a high of $27.30. The average price target represents an increase of ... It's been a pretty great week for NeoGenomics, Inc. (NASDAQ:NEO) shareholders, with its shares surging 19% to US$11.88 in the week since its latest quarterly results. It was a respectable set of ...One great example is NeoGenomics, Inc. ( NASDAQ:NEO) which saw its share price drive 125% higher over five years. On top of that, the share price is up 77% in about a quarter. The company reported ...Barclays PLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 12.4% during the 2nd quarter, according to the company in its most recent 13F filing with the ...Description. A stock index simply represents a basket of underlying stocks. Indexes can be either price-weighted or capitalization-weighted. In a price-weighted index, such as the Dow Jones Industrial Average, the individual stock prices are simply added up and then divided by a divisor, meaning that stocks with higher prices have a higher weighting in the index …NeoVolta Inc. Common Stock (NEOV) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.NeoGenomics Probability Of Bankruptcy is currently at 32.62%. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress.

FT. MYERS, FL / ACCESSWIRE / October 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report ...

Nov 28, 2023 · NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) was the target of unusually large options trading activity on Monday. Stock investors bought 3,696 call options on the company. This represents an increase of 695% compared to the average volume of 465 call options. Insider Buying and Selling In other NeoGenomics news, General Counsel Alicia C. Olivo […] Webull offers NEO Ent Holdg (NEO) historical stock prices, in-depth market analysis, NASDAQ: NEO real-time stock quote data, in-depth charts, free NEO options chain data, and a fully built financial calendar to help you invest smart.6 nov 2023 ... NeoGenomics, Inc. 2023 Q3 - Results - Earnings Call Presentation · Q3: 2023-11-06 Earnings Summary · NeoGenomics, Inc (NEO) Q3 2023 Earnings Call ...Graham Capital Management L.P. lessened its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 57.8% during the second quarter, according to the company in its most recent 13F ...NeoGenomics Inc (NASDAQ:NEO) $19.28 0.185 [0.97%] Last update: 1:00PM (Delayed 15-Minutes) Get Real Time Here $19.28 0 [0.00%] Profile News …The forecasts range from a low of 17.17 to a high of $27.30. The average price target represents an increase of 70.79% from its latest reported closing price of 12.65. leaderboard of companies ...(NASDAQ: NEO) Neogenomics's forecast annual revenue growth rate of 5.43% is forecast to beat the US Diagnostics & Research industry's average forecast revenue ...4 months ago - GlobeNewsWire NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors FT. MYERS, FL / ACCESSWIRE / June 29, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced the appointment of Elizabeth ... 5 months ago - AccesswireThe latest price target for NeoGenomics ( NASDAQ: NEO) was reported by Morgan Stanley on Wednesday, November 8, 2023. The analyst firm set a price target for 17.00 expecting NEO to fall to within ...

Neogenomics (NASDAQ: NEO) is owned by 93.58% institutional shareholders, 37.64% Neogenomics insiders, and 0.00% retail investors. Electric Co General is the largest individual Neogenomics shareholder, owning 15.00M shares representing 11.77% of the company. Electric Co General's Neogenomics shares are currently valued at $285.00M.Published Oct 25, 2021 12:19PM EDT Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far …Nov 7, 2023 · November 7, 2023 at 9:01 AM · 14 min read. NeoGenomics, Inc. (NASDAQ: NEO) Q3 2023 Earnings Call Transcript November 6, 2023. Operator: Greetings. Welcome to the NeoGenomics Third Quarter 2023 ... The latest Neogenomics stock prices, stock quotes, news, and NEO history to help you invest and trade smarter. ... Nasdaq 100; Nasdaq Composite; FTSE 100; Nikkei 225; DAX 40; Hang Seng; Kospi;Instagram:https://instagram. crypto trading coursesed stock dividendbest free expense report appnyse ko compare NeoGenomics (NEO) is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat ... build my sopavav stock price NeoGenomics, Inc. (NASDAQ:NEO) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for NEO is 39. Stocks with higher ... what brokers trade otc stocks Wall Street Analysts See a 28.17% Upside in NeoGenomics (NEO): Can the Stock Really Move This High? The average of price targets set by Wall Street analysts indicates a …The NASDAQ 100 Pre-Market Indicator is down -43.28 to 15,904.59. The total Pre-Market volume is currently 39,423,611 shares traded.The following are the most …Find the latest dividend history for NeoGenomics, Inc. Common Stock (NEO) at Nasdaq.com.